These include, but are not exclusive to, Beta Thalassaemia [56], Glut1 Deficiency Syndrome [57], Fetal Alcohol Syndrome [58], Obstructive Sleep Apnea Syndrome [59], and (though not strictly using GMM) the study of Down Syndrome patients [60]. This evidence concerns the gene SLC2A1 and beta thalassemia.